A site where you can find recommended contractors for non-clinical testing｜effical " Non-Clinical CROs and Agencies " NAS LABORATORY CO., LTD.

NAS LABORATORY CO., LTD.

Table of Contents

NAS LABORATORY CO., LTD. is a contract research organization specializing in the housing, management, and evaluation of industrial and livestock animals. The company offers safety and functional assessments of the feed and veterinary pharmaceutical drugs at its in-house facilities. They provide non-clinical study that is tailored specifically to the livestock industry.

Features of NAS LABORATORY CO., LTD.’s Non-clinical Contract Services

Reliable testing framework specialized in veterinary pharmaceuticals

NAS LABORATORY CO., LTD. is a registered testing facility under Japan’s Ministry of Agriculture, Forestry and Fisheries (MAFF). They are authorized to conduct efficacy and safety evaluations for veterinary drugs and feed additives.
The laboratory has a particular strength in field trials, clinical studies, and pharmacological evaluations using livestock animals. By utilizing their own facilities, they offer an integrated system that covers a broad range of study types.

To ensure high data reliability, NAS LABORATORY CO., LTD. also participates in third-party proficiency testing programs. Backed by an advanced husbandry and management system, the laboratory delivers high-quality non-clinical research services specialized in livestock and veterinary science.

Comprehensive support from study design to regulatory submission

NAS LABORATORY CO., LTD. provides end-to-end support from protocol design and data collection to report preparation. They can also assist clients with documentation required for regulatory submissions.

Experienced staff with deep expertise in veterinary drug development provide consulting-level advice on regulatory pathways. Under a GLP-compliant quality management system, NAS LABORATORY CO., LTD. efficiently manages the entire workflow from study execution to documentation, offering flexible support in accordance to Japanese regulatory requirements.

Diverse housing environments and flexible study designs across animal species

The laboratory operates a wide range of facilities suitable for various livestock species, including beef cattle, dairy cattle, swine, and poultry. Study designs can be tailored to the biological characteristics and production environment of each species.

A key strength of NAS LABORATORY CO., LTD. is their capability to perform practical, field-oriented studies, such as evaluating feed additives under real farming conditions or conducting applied performance tests. Facility tours and pre-study consultations are also available. This enables future clients to collaboratively establish study frameworks that align with their project goals.

3 Specialized Pre-clinical CROs for Advanced Drug Discovery

Examples of Disease Models at NAS LABORATORY CO., LTD.

No case studies were available on the official website.

Non-clinical Study Examples from NAS LABORATORY CO., LTD.

No case studies were available on the official website.

Company Information

Address	1885-2 Komaino, Narita, Chiba, Japan
Tel	0476-35-5766
Website	https://www.naslabo.co.jp/

3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation

SMC Laboratories, Inc.

Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)

SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.
With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.

Consult study design and disease model development
with SMC Laboratories, Inc.

Consult SMC Laboratories
Call us

Safety Studies
Comprehensive Safety Evaluation for FIH Applications

Labcorp Holdings Inc.
(Labcorp Drug Development)

Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)

Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.

Consult Labcorp Holdings Inc.
Discuss GLP/ICH-compliant study design for your FIH submission.

To labcorp.
Call us

Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation

PhoenixBio Co., Ltd.

Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)

PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.
The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

Consult Phoenix Bio for PK/PD analysis with a clinical focus

Phoenix Bio.
Call us